165 related articles for article (PubMed ID: 16533725)
1. The effect of fludarabine on interferon-gamma production by lymphoid cells from healthy donors and patients with B-cell chronic lymphocytic leukemia.
Gamberale R; Fernández-Calotti P; Sánchez-Avalos J; Alberto MF; Geffner J; Giordano M
Haematologica; 2006 Apr; 91(4):574-6. PubMed ID: 16533725
[TBL] [Abstract][Full Text] [Related]
2. Fludarabine-induced autoimmune hemolytic anemia in a CLL patient: rituximab as the treatment of choice?
Smolej L
Leuk Res; 2007 Feb; 31(2):267; author reply 268-9. PubMed ID: 16716397
[No Abstract] [Full Text] [Related]
3. Severe autoimmune hemolytic anemia in eight patients treated with fludarabine.
Gonzalez H; Leblond V; Azar N; Sutton L; Gabarre J; Binet JL; Vernant JP; Dighiero G
Hematol Cell Ther; 1998 Jun; 40(3):113-8. PubMed ID: 9698219
[TBL] [Abstract][Full Text] [Related]
4. Severe autoimmune hemolytic anemia following fludarabine therapy in a patient with chronic lymphocytic leukemia.
Tsiara S; Christou L; Konstantinidou P; Panteli A; Briasoulis E; Bourantas KL
Am J Hematol; 1997 Apr; 54(4):342. PubMed ID: 9092698
[No Abstract] [Full Text] [Related]
5. Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.
Nishida H; Murase T; Ueno H; Park JW; Yano T; Ikeda Y
Leuk Res; 2006 Dec; 30(12):1589-90. PubMed ID: 16542723
[TBL] [Abstract][Full Text] [Related]
6. Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia.
Maclean R; Meiklejohn D; Soutar R
Br J Haematol; 1996 Mar; 92(3):768-9. PubMed ID: 8616054
[No Abstract] [Full Text] [Related]
7. [Fludarabine and fatal hemolytic anemia].
López L; del Villar V; Pascual T
Sangre (Barc); 1995 Aug; 40(4):335-6. PubMed ID: 7482124
[No Abstract] [Full Text] [Related]
8. Mixed-type autoimmune hemolytic anemia following fludarabine treatment in a patient with chronic lymphocytic leukemia/small cell lymphoma.
Vick DJ; Byrd JC; Beal CL; Chaffin DJ
Vox Sang; 1998; 74(2):122-6. PubMed ID: 9501412
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine.
Di Raimondo F; Giustolisi R; Cacciola E; O'Brien S; Kantarjian H; Robertson LB; Keating MJ
Leuk Lymphoma; 1993 Sep; 11(1-2):63-8. PubMed ID: 8220155
[TBL] [Abstract][Full Text] [Related]
10. Oral fludarabine treatment of cutaneous infiltration in a patient with B-cell chronic lymphocytic leukaemia.
Ural AU; Kubar A; Avcu F; Tastan HB; Safali M; Nevruz O; Cetin T
Clin Exp Dermatol; 2007 Mar; 32(2):151-4. PubMed ID: 17244344
[TBL] [Abstract][Full Text] [Related]
11. Role of decreased production of interleukin-10 and interferon-gamma in spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes in vitro.
Djurdjevic P; Zelen I; Ristic P; Baskic D; Popovic S; Arsenijevic N
Arch Med Res; 2009 Jul; 40(5):357-63. PubMed ID: 19766898
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of single-agent bortezomib for the treatment of patients with fludarabine-refractory B-cell chronic lymphocytic leukemia.
Faderl S; Rai K; Gribben J; Byrd JC; Flinn IW; O'Brien S; Sheng S; Esseltine DL; Keating MJ
Cancer; 2006 Sep; 107(5):916-24. PubMed ID: 16832816
[TBL] [Abstract][Full Text] [Related]
13. [Selective aplasia of the red-cell series after fludarabine administration in a patient with chronic B-cell lymphatic leukemia].
Antich Rojas J; Balaguer H; Cladera A
Sangre (Barc); 1997 Jun; 42(3):254-6. PubMed ID: 9381277
[No Abstract] [Full Text] [Related]
14. Successful reduced-intensity allogeneic transplantation utilizing a fludarabine-based preparative regimen in a patient with chronic lymphocytic leukaemia and a history of fludarabine-associated autoimmune haemolytic anaemia.
Ford CD; Asch J; Pulsipher M; Petersen FB
Br J Haematol; 2004 Aug; 126(4):623-4. PubMed ID: 15287959
[No Abstract] [Full Text] [Related]
15. [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment].
Smolej L; Andrýs C; Krejsek J; Belada DZ; Zák P; Siroký O; Malý J
Vnitr Lek; 2007 Nov; 53(11):1171-6. PubMed ID: 18277626
[TBL] [Abstract][Full Text] [Related]
16. Fludarabine and autoimmune hemolytic anemia in chronic lymphocytic leukemia.
Longo G; Gandini G; Ferrara L; Torelli U; Emilia G
Eur J Haematol; 1997 Aug; 59(2):124-5. PubMed ID: 9293862
[No Abstract] [Full Text] [Related]
17. Fludarabine and hemolytic anemia in chronic lymphocytic leukemia.
Hamblin TJ; Orchard JA; Myint H; Oscier DG
J Clin Oncol; 1998 Sep; 16(9):3209-10. PubMed ID: 9738600
[No Abstract] [Full Text] [Related]
18. Apoptotic effect of fludarabine is independent of expression of IAPs in B-cell chronic lymphocytic leukemia.
Silva KL; Vasconcellos DV; Castro ED; Coelho AM; Linden R; Maia RC
Apoptosis; 2006 Feb; 11(2):277-85. PubMed ID: 16502265
[TBL] [Abstract][Full Text] [Related]
19. Fludarabine induced autoimmune haemolytic anaemia in a patient with chronic lymphocytic leukaemia.
Syed NN; Khurshid M
J Pak Med Assoc; 2006 Jan; 56(1):44-5. PubMed ID: 16454137
[TBL] [Abstract][Full Text] [Related]
20. The novel nuclear factor-kappaB inhibitor LC-1 is equipotent in poor prognostic subsets of chronic lymphocytic leukemia and shows strong synergy with fludarabine.
Hewamana S; Lin TT; Jenkins C; Burnett AK; Jordan CT; Fegan C; Brennan P; Rowntree C; Pepper C
Clin Cancer Res; 2008 Dec; 14(24):8102-11. PubMed ID: 19088025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
